How do protein aggregates escape quality control in neurodegeneration?

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Protein aggregates are key indicators of neurodegenerative diseases.
• The protein quality control (PQC) system normally prevents protein misfolding and aggregation.
• Dysfunction in PQC allows proteins to accumulate, contributing to disease pathogenesis.

Purpose of the Study:

• To review recent advances in understanding the role of PQC in protein aggregation and neurodegeneration.
• To highlight the involvement of the protein Tau in Alzheimer's disease and other tauopathies.
• To examine new insights into amyloid fibril structures and phase separation in PQC-related diseases.

Main Methods:

• Literature review of current research on protein quality control.
• Focus on the protein Tau and its aggregation in neurodegenerative conditions.
• Examination of studies on amyloid fibril formation and phase separation.

Main Results:

• Specific PQC components may be altered in neurodegenerative diseases.
• Most chaperones and degradation factors remain unchanged in late-stage disease.
• Advances in understanding fibril structures and phase separation offer new perspectives on PQC's role.

Conclusions:

• Understanding PQC's role in early-stage neurodegeneration is crucial.
• Further research into quality control factors is a key challenge in the field.
• PQC dysfunction is central to protein aggregation diseases like Alzheimer's.